Effect of Nephropathy Prescription I on the Expression of Angptl3 and Podocyte-Associated Protein in Mice with Adriamycin-Induced Nephropathy

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Serum biochemical indices</td><td class="align_center">Method</td><td class="align_center">Kit</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Serum albumin</td><td class="align_center">ELISA</td><td class="align_center">Mouse Albumin ELISA Kit (Bethyl Laboratories)</td></tr><tr><td class="align_left">Total cholesterol and triglyceride</td><td class="align_center">GPO-PAP</td><td class="align_center">Nanjing Jiancheng Institute of Bioengineering</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Evidence-Based Complementary and Alternative Medicine

tab1

Table 1

Table 1: Effect of Nephropathy Prescription I on the Expression of Angptl3 and Podocyte-Associated Protein in Mice with Adriamycin-Induced Nephropathy 

Table 1 | Effect of Nephropathy Prescription I on the Expression of Angptl3 and Podocyte-Associated Protein in Mice with Adriamycin-Induced Nephropathy 